A bipartisan group of U.S. House members unveiled legislation Monday that would pause drug manufacturer 340B rebates, establish a new [...] …
Articles by : Luke Zarzecki, National Correspondent
A small San Francisco-based drugmaker on Tuesday announced it will implement 340B contract pharmacy restrictions for its only U.S.-approved medication, [...] …
Please Login or Become a Paid Subscriber to View this Content
Editor’s Note: As the 340B program draws increased attention from researchers, policymakers and commentators, 340B Report has launched a new [...] …
Please Login or Become a Paid Subscriber to View this Content
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
Some drug pricing advocates are urging other states to adopt a vetoed Virginia proposal that would have tied drug payments [...] …
Please Login or Become a Paid Subscriber to View this Content
State 340B legislative activity could heat up again as providers look for protections from the growing number of manufacturer claims [...] …
Please Login or Become a Paid Subscriber to View this Content
A Japanese drugmaker recently announced 340B refunds for covered entities that purchased an anti-seizure medication in 2023, while a South [...] …
Please Login or Become a Paid Subscriber to View this Content
A budget bill awaiting Florida Gov. Ron DeSantis’ (R) signature would restore funding for the state’s AIDS Drug Assistance Program [...] …
Please Login or Become a Paid Subscriber to View this Content
A law firm representing 340B providers urged federal regulators Wednesday to investigate Eli Lilly’s new 340B in-house pharmacy claims data [...] …
Please Login or Become a Paid Subscriber to View this Content
Attorneys representing both 340B covered entity and drug manufacturer perspectives joined 340B Report’s editorial team Wednesday to discuss state 340B [...] …